HIMA hires Medicare lobbyist
This article was originally published in The Gray Sheet
Washington D.C. attorney Deborah Steelman reportedly has been retained by the Health Care Manufacturers Association to lobby the federal government on Medicare-related issues of the Balanced Budget Act of 1997. Steelman, who during the Bush Administration headed a blue ribbon charged with looking at the Medicare program, includes the Pharmaceutical and Manufacturers of America among her clients
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.